C45 - The role of ribociclib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) early breast cancer: the EarLEE adjuvant clinical trials program
| Autor: | De Laurentiis, M., Montemurro, F., Bachelot, T., Martin, M., Barrios, C., Kaufman, B., Schmid, P., Alba, E., Dieras, V., Mondal, S., Chakravartty, A., Shilkrut, M., Miller, M., Untch, M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2017 28 Supplement 6:vi37-vi37 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|